FDA Class II · Drug · July 29, 2026
Divalproex Sodium Delayed-Release Tablets recall — Bionpharma Inc.
Presence of Foreign Tablets/Capsules
Official ID D-0742-2026 · Official record ↗
Bionpharma recalls
Recall found. Bionpharma is named in FDA Class II recall D-0742-2026 covering Divalproex Sodium Delayed-Release Tablets. Hazard: Presence of Foreign Tablets/Capsules Identifying details: Lot# 704C003, Exp. 12/31/2028. Status: Ongoing.
Models with recalls
All Bionpharma recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked September 7, 2026 at 6:00 AM UTC.